This chapter comprehensively explores the pivotal role of artificial intelligence (AI) in drug
discovery and development, encapsulating its potentials, methodologies, real-world …

Cardiovascular diseases exert a significant burden on the healthcare system worldwide.
This narrative literature review discusses the role of artificial intelligence (AI) in the field of …

Artificial intelligence (AI) is rapidly transforming healthcare, and one of its most promising
applications is in the diagnosis and treatment of diseases. AI algorithms can analyze vast …

AI-assisted screening and prevention programs have the potential to revolutionize disease
management and improve public health outcomes. By harnessing the power of artificial …

Recent years have witnessed a significant convergence of artificial intelligence (AI) within
the healthcare sector. This chapter explores the transformative potential and challenges …

Background Clinical prediction is integral to modern healthcare, leveraging current and
historical medical data to forecast health outcomes. The integration of Artificial Intelligence …

The chemotactic cytokine fractalkine (FKN, chemokine CX3CL1) has unique properties
resulting from the combination of chemoattractants and adhesion molecules. The soluble …

The discovery of anti‐retroviral (ARV) drugs over the past 36 years has introduced various
classes, including nucleoside/nucleotide reverse transcriptase inhibitors, non‐nucleoside …

In the evolution of modern medicine, artificial intelligence (AI) has been proven to provide an
integral aspect of revolutionizing clinical diagnosis, drug discovery, and patient care. With …

Background: Lupus osteoarthritis is a disabling complication of systemic lupus
erythematosus (SLE) caused by persistent inflammation and biomechanical factors. The …